[go: up one dir, main page]

BR0108128A - Pluraflavinas e derivados das mesmas, processo para a sua preparação e uso das mesmas - Google Patents

Pluraflavinas e derivados das mesmas, processo para a sua preparação e uso das mesmas

Info

Publication number
BR0108128A
BR0108128A BR0108128-4A BR0108128A BR0108128A BR 0108128 A BR0108128 A BR 0108128A BR 0108128 A BR0108128 A BR 0108128A BR 0108128 A BR0108128 A BR 0108128A
Authority
BR
Brazil
Prior art keywords
alkenyl
alkyl
preparation
alkynyl
pluraflavins
Prior art date
Application number
BR0108128-4A
Other languages
English (en)
Inventor
Laszlo Vertesy
Klaus Ehrlich
Martin Knauf
Joachim Wink
Francis P Barbone
Elaine A Powers
Elizabeth A Cashman
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of BR0108128A publication Critical patent/BR0108128A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/58Preparation of O-glycosides, e.g. glucosides having an oxygen atom of the saccharide radical directly bound through only acyclic carbon atoms to a non-saccharide heterocyclic ring, e.g. bleomycin, phleomycin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/60Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

"PLURAFLAVINAS E DERIVADOS DAS MESMAS, PROCESSO PARA A SUA PREPARAçãO E USO DAS MESMAS. A invenção de refere-se a um composto da fórmula (I), na qual R~ 1~ é um açúcar, R~ 2~ é CH~ 2~-O-(R~ 7~)m, R~ 7~ representando um açúcar, ou R~ 2~ é -COOH; R~ 3~ é um grupo que compreenda epóxi, C~ 1~-C~ 6~-alquila ou C~ 2~-C~ 6~ alquenila, não-substituídos ou substituídos com pelo menos um OH; R~ 5~ é H, C~ 1~-C~ 6~-alquila, C~ 2~-C~ 6~-alquenila e C~ 2~-C~ 6~ alquinila, R~ 4~,R~ 6~,R~ 8~ e R~ 10~ são cada um de modo independente um do outro H, C~ 1~-C~ 6~-alquila, C~ 2~-C~ 6~-alquenila e C~ 2~-C~ 6~ alquinila, -X~ 2~H, ou -X~ 2~R~ 12~ ou R~ 4~ e R~ 6~ em conjunto e/ou R~ 8~ e R~ 10~ em conjunto são = X~ 2~; X~ 2~ é O, NH, N-C~ 1~-C~ 6~-alquila, N-C~ 2~-C~ 6~-alquenila, ou S, R~ 12~ é C~ 1~-C~ 6~-alquenila, C~ 2~-C~ 6~-alquinila, C~ 2~-C~ 6~ alquinila, arila ou acila, e m e n são 1 ou 2; e os sais fisiologicamente aceitáveis dos mesmos. Os compostos podem ser obtidos a partir de uma cultura do microorganismo da espécie Actinomycetales HAG 003959, DSM 12931, através de fermentação. Por conseq³ência, a invenção refere-se a um processo para a preparação dos mesmos e o uso dos compostos como agentes farmacêuticos, por exemplo como agentes antitumor.
BR0108128-4A 2000-02-18 2001-02-15 Pluraflavinas e derivados das mesmas, processo para a sua preparação e uso das mesmas BR0108128A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00103540A EP1125944A1 (de) 2000-02-18 2000-02-18 Pluraflavine und Derivate davon, Verfahren zu ihrer Herstellung und Verwendung derselben
PCT/EP2001/001660 WO2001060832A2 (en) 2000-02-18 2001-02-15 Pluraflavins and derivatives thereof, process for their preparation and use thereof

Publications (1)

Publication Number Publication Date
BR0108128A true BR0108128A (pt) 2003-02-25

Family

ID=8167898

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0108128-4A BR0108128A (pt) 2000-02-18 2001-02-15 Pluraflavinas e derivados das mesmas, processo para a sua preparação e uso das mesmas

Country Status (31)

Country Link
US (1) US6500936B2 (pt)
EP (2) EP1125944A1 (pt)
JP (1) JP4801307B2 (pt)
KR (1) KR100743380B1 (pt)
CN (1) CN1162441C (pt)
AR (1) AR027436A1 (pt)
AT (1) ATE255120T1 (pt)
AU (2) AU4240401A (pt)
BR (1) BR0108128A (pt)
CA (1) CA2400237C (pt)
CZ (1) CZ303810B6 (pt)
DE (1) DE60101313T2 (pt)
DK (1) DK1259523T3 (pt)
EE (1) EE05137B1 (pt)
ES (1) ES2207609T3 (pt)
HK (1) HK1052709B (pt)
HR (1) HRP20020672B1 (pt)
HU (1) HU228332B1 (pt)
IL (2) IL151216A0 (pt)
ME (1) ME00179B (pt)
MX (1) MXPA02006919A (pt)
NO (1) NO323413B1 (pt)
PL (1) PL204842B1 (pt)
PT (1) PT1259523E (pt)
RS (1) RS49991B (pt)
RU (1) RU2255940C2 (pt)
SI (1) SI1259523T1 (pt)
SK (1) SK286691B6 (pt)
TR (1) TR200302180T4 (pt)
WO (1) WO2001060832A2 (pt)
ZA (1) ZA200206795B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6989386B2 (en) * 2002-04-30 2006-01-24 Dana-Farber Cancer Institute Pharmaceutically active ornithine derivatives, ammonium salts thereof and methods of making same
CN101921300B (zh) * 2009-06-10 2014-04-02 上海来益生物药物研究开发中心有限责任公司 一种异黄酮苷类化合物及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4187292A (en) * 1977-03-31 1980-02-05 Takeda Chemical Industries, Ltd. Antibiotics produced from the microorganism nocardice
EP0274545B1 (en) * 1986-07-21 1992-12-02 Kyowa Hakko Kogyo Co., Ltd. Novel substances dc-92b and dc-92d, and process for their preparation
AU623923B2 (en) * 1988-07-22 1992-05-28 Masco Corporation A small hand-held shower head for domestic sinks connected to a faucet
US5001058A (en) * 1988-09-19 1991-03-19 Bristol-Myers Company BU-3839T antibiotic
PT93070A (pt) * 1989-02-07 1990-08-31 Abbott Lab Processo de preparacao de altromicinas e de composicoes farmaceuticas que as contem
US5168100A (en) * 1990-03-16 1992-12-01 Sapporo Breweries Limited Hp530 compounds and process for preparing the same
CN101688424B (zh) * 2007-07-06 2013-04-24 瑞泰控股公司 可收回的安全屏障及其操作方法

Also Published As

Publication number Publication date
CA2400237A1 (en) 2001-08-23
HK1052709A1 (en) 2003-11-21
DE60101313D1 (de) 2004-01-08
EE05137B1 (et) 2009-02-16
AR027436A1 (es) 2003-03-26
PT1259523E (pt) 2004-04-30
CN1404484A (zh) 2003-03-19
HRP20020672A2 (en) 2004-12-31
EP1259523B1 (en) 2003-11-26
ES2207609T3 (es) 2004-06-01
WO2001060832A3 (en) 2002-01-31
PL204842B1 (pl) 2010-02-26
HUP0204393A2 (hu) 2003-07-28
DE60101313T2 (de) 2004-09-30
JP2003523346A (ja) 2003-08-05
TR200302180T4 (tr) 2004-03-22
CA2400237C (en) 2008-12-30
NO20023845L (no) 2002-10-10
CN1162441C (zh) 2004-08-18
IL151216A (en) 2009-12-24
ZA200206795B (en) 2003-11-19
EP1125944A1 (de) 2001-08-22
CZ20022826A3 (cs) 2002-11-13
IL151216A0 (en) 2003-04-10
SK286691B6 (sk) 2009-03-05
YU57602A (sh) 2005-11-28
HK1052709B (zh) 2005-02-04
HUP0204393A3 (en) 2007-10-29
JP4801307B2 (ja) 2011-10-26
ME00179B (me) 2011-02-10
SI1259523T1 (en) 2004-04-30
NO323413B1 (no) 2007-04-30
SK11802002A3 (sk) 2003-02-04
CZ303810B6 (cs) 2013-05-15
AU2001242404B2 (en) 2005-04-14
RU2255940C2 (ru) 2005-07-10
RU2002124772A (ru) 2004-02-20
MXPA02006919A (es) 2004-04-05
EP1259523A2 (en) 2002-11-27
KR100743380B1 (ko) 2007-07-30
HRP20020672B1 (en) 2010-12-31
PL358297A1 (en) 2004-08-09
DK1259523T3 (da) 2004-03-22
HU228332B1 (en) 2013-03-28
KR20020086539A (ko) 2002-11-18
US6500936B2 (en) 2002-12-31
EE200200438A (et) 2003-12-15
MEP28608A (en) 2010-10-10
ATE255120T1 (de) 2003-12-15
WO2001060832A2 (en) 2001-08-23
RS49991B (sr) 2008-09-29
NO20023845D0 (no) 2002-08-14
AU4240401A (en) 2001-08-27
US20020028921A1 (en) 2002-03-07

Similar Documents

Publication Publication Date Title
BR9911771A (pt) Compostos cìclicos substituìdos, um processo para sua preparação e composições farmacêuticas que contêm os mesmos
FR2629819B1 (fr) Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii
BR9812653A (pt) Derivados de carboxamidotiazóis, sua preparação, as composições farmacêuticas que os contêm
BR0213350A (pt) Derivados benzoxazina e benzotiazina e composições farmacêuticas contendo os mesmos
BR0212481A (pt) Composto, composição farmacêutica, método de preparação de uma composição farmacêutica, processo para a preparação de um composto, e, uso de um composto
BR0312648A (pt) Processo para preparação de certos compostos pirrolo triazina
BR0214142A (pt) Derivados e intermediários de n-adamantilmetila como composições farmacêuticas e processos para sua preparação
BR0112224A (pt) Composto, composição farmacêutica, uso de um composto ou de um sal, solvato ou pró-droga farmaceuticamente aceitável do mesmo, e, processo para preparar um composto
PT99402A (pt) Processo para a preparacao de derivados de imino ciclicos e de composicoes farmaceuticas que os contem
MY103850A (en) Phenol substituted gem-diphosphonate derivatives, process for their preparation and pharmaceutical compositions containing them.
BR9813022A (pt) Derivados de ésteres hidroxiacéticos, seu processo de preparação e sua utilização como intermediários de sìntese
BR0010716A (pt) Compostos de fenila substituìdos com atividade imunossupressora e composições farmacêuticas
BR0315143A (pt) Composto, processo para a preparação dos (r) e (s) - enanciÈmeros individuais ou misturas de enanciÈmeros e sais farmaceuticamente aceitáveis de um composto, composição farmacêutica, e, uso de um composto
BR9812808A (pt) 3,6-hemicetais da classe de 9a-azalidas, processo para preparação dos mesmos, seuuso farmacêutico, bem como composição farmacêutica compreendendo os mesmos
PT81855B (pt) Processo de preparacao de arilciclobutilalquilaminas e de composicoes farmaceuticas que as contem
BR0003848A (pt) Compostos de piridina, processo para sua preparação e composições farmacêuticas que os contêm
BR0016130A (pt) Composto, formulação farmacêutica, e, uso de um composto
PT69618A (de) Neue imidazolderivate verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praparate
BR0104471A (pt) Compostos de ciclobutenodiona, um processo para a preparação dos mesmos e composições farmacêuticas que contêm os mesmos
KR890006625A (ko) 2,2-디메틸크로멘 유도체, 그의 제조방법 및 그것을 함유하는 약학 조성물
BR0108128A (pt) Pluraflavinas e derivados das mesmas, processo para a sua preparação e uso das mesmas
MX9603272A (es) Nuevos derivados de aminoacidos, procedimiento para su preparacion y composiciones farmaceuticas que contienen estos compuestos.
FR2804958B1 (fr) Derives de xanthine, leur procede de preparation et les intermediaires de ce procede, leur application comme medicament et les compositions pharmaceutiques les renfermant
KR960017649A (ko) 아미노사이클로펜탄 유도체
SG146692A1 (en) Melanin concentrating hormone antagonists

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH (DE)

Free format text: ALTERADO DE: AVENTIS PHARMA DEUTSCHLAND GMBH

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07F Notification of approval that there is no relation to art. 229 of lpi (pipeline patents) [chapter 7.6 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: C07H 17/04 (2006.01), A61K 31/70 (2006.01), A61P 3

B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements